Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Amyloidosis Transthyretin”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT07766135
What this trial is testing

Liver and Coagulation Disorders in Cardiac Transthyretin Amyloidosis

Who this might be right for
Transthyretin (TTR) Amyloid CardiomyopathyCardiac AmyloidosisCardiomyopathies+2 more
University of Messina 70
Not applicableLooking for participantsNCT07112924
What this trial is testing

CCM OPEN HF Registry

Who this might be right for
Heart Failure
Impulse Dynamics 5,500
Not applicableStudy completedNCT04201418
What this trial is testing

Observational Study to Evaluate the Effectiveness of Patisiran in Patients With Polyneuropathy of ATTRv Amyloidosis With a V122I or T60A Mutation

Who this might be right for
Hereditary Transthyretin-mediated (ATTRv) AmyloidosisPolyneuropathy
Alnylam Pharmaceuticals 67
Not applicableWithdrawnNCT02462213
What this trial is testing

Prospective Identification of Cardiac Amyloidosis by Cardiac Magnetic Resonance Imaging

Who this might be right for
AmyloidosisParaproteinemiasCardiomyopathies
University of Cincinnati
Not applicableStudy completedNCT06201832
What this trial is testing

Cardiac Amyloidosis in HFpEF Tunisian Patients

Who this might be right for
Cardiac AmyloidosisHeart Failure With Preserved Ejection FractionEchocardiography+4 more
University Tunis El Manar 87
Not applicableUnknownNCT05896904
What this trial is testing

Clinical Comparison of Patients With Transthyretin Cardiac Amyloidosis and Patients With Heart Failure With Reduced Ejection Fraction

Who this might be right for
Transthyretin Amyloid CardiomyopathyHeart Failure
Aarhus University Hospital Skejby 100
Not applicableLooking for participantsNCT06978660
What this trial is testing

Multicenter Study for the Validation of an AI-based ECG Platform for Early Cardiac Amyloidosis Diagnosis

Who this might be right for
Transthyretin Cardiac Amyloidosis
Idoven 1903 S.L. 2,200
Not applicableLooking for participantsNCT07308704
What this trial is testing

Deep Learning For Echo Analysis, Tracking, And Evaluation

Who this might be right for
CardiomyopathyIschemic Heart DiseaseCardiac Amyloidosis
Mayo Clinic 10,040,000
Not applicableStudy completedNCT05557162
What this trial is testing

Artificial Intelligence Enhanced ECG to Detect Cardiac Amyloidosis

Who this might be right for
Cardiac Amyloidosis
Mayo Clinic 20,143
Large-scale testing (Phase 3)Not Yet RecruitingNCT07789483
What this trial is testing

An Open-Label Study to Evaluate the Long-Term Safety and Efficacy of ALXN2220 in Adults With Transthyretin Amyloid Cardiomyopathy

Who this might be right for
Transthyretin Amyloid Cardiomyopathy (ATTR-CM)
Alexion Pharmaceuticals, Inc. 1,180
Not applicableStudy completedNCT00628745
What this trial is testing

Transthyretin Amyloidosis Outcome Survey (THAOS)

Who this might be right for
Transthyretin Gene MutationsTransthyretin Amyloidosis
Pfizer 6,718
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07743957
What this trial is testing

Selinexor, Daratumumab, and Dexamethasone (XDd) for Light-Chain Cardiac Amyloidosis

Who this might be right for
Light-chain Cardiac Amyloidosis
Beijing Anzhen Hospital 63
Not applicableNot Yet RecruitingNCT07567508
What this trial is testing

Early Detection of Concealed Cardiac Amyloidosis Using AI-ECG and CT-Derived Extracellular Volume in Patients With Atrial Fibrillation

Who this might be right for
Atrial Fibrillation (AF)Cardiac Amyloidosis
Samsung Medical Center 500
Not applicableUnknownNCT05938218
What this trial is testing

Virtual Reality Assisted Patient Empowerment: Diagnose ATTR-Amyloidosis And Start Treatment

Who this might be right for
Amyloidosis CardiacVirtual Reality
Heinrich-Heine University, Duesseldorf 60
Testing effectiveness (Phase 2)UnknownNCT06539208
What this trial is testing

A Phase I/IIa，Open-label, Single Ascending Dose and Dose-expansion Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of YOLT-201 in Patients With Transthyretin Amyloidosis Polyneuropathy (ATTR-PN) or Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM)

Who this might be right for
Transthyretin Amyloidosis PolyneuropathyTransthyrexin Amyloidosis Cardiomyopathy
YolTech Therapeutics Co., Ltd 31
Large-scale testing (Phase 3)Enrolling By InvitationNCT05667493
What this trial is testing

An Extension Study to Assess Long-Term Safety of Eplontersen in Adults With Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR-CM)

Who this might be right for
Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR CM)
Ionis Pharmaceuticals, Inc. 1,400
Post-approval studies (Phase 4)Looking for participantsNCT07306949
What this trial is testing

Real-Life Clinical Efficacy of Acoramidis in Participants With ATTR-CM and Association With Cardiac Biomarkers

Who this might be right for
Transthyretin-type Cardiac Amyloidosis
Alexion Pharmaceuticals, Inc. 200
Not applicableStudy completedNCT03996382
What this trial is testing

Prevalence of Wild Type Transthyretin Cardiac Amyloidosis in Patients Operated for Idiopathic Carpal Tunnel Syndrome

Who this might be right for
Amyloidosis CardiacCarpal Tunnel Syndrome
Aarhus University Hospital Skejby 120
Testing effectiveness (Phase 2)WithdrawnNCT04843020
What this trial is testing

ION-682884 in Patients With TTR Amyloid Cardiomyopathy

Who this might be right for
Transthyretin Amyloid Cardiopathy
Brigham and Women's Hospital
Not applicableUnknownNCT05772091
What this trial is testing

Prognostic Value of Echocardiographic Parameters Based on Machine Learning Approach

Who this might be right for
Transthyretin Cardiac Amyloidosis
Pr. Nicolas GIRERD 1,000
Next Page